Literature DB >> 2901726

Nucleoside imidodiphosphates synthesis and biological activities.

J Tomasz1, M M Vaghefi, P C Ratsep, R C Willis, R K Robins.   

Abstract

The synthesis of imidodiphosphate analogues of natural nucleoside 5'-diphosphates including adenosine 5'-imidodiphosphate (4a), guanosine 5'-imidodiphosphate (4b), 2'-deoxyadenosine 5'-imidodiphosphate (4c), and 2'-deoxy-guanosine 5'-imidodiphosphate (4d) has been accomplished for the first time. These compounds are the products of the reaction between nucleosides and trichloro [(dichlorophosphoryl)imido] phosphorane in trimethyl phosphate. Some of the major by-products of the reaction including 5'-deoxy-5'-chloro nucleosides are discussed. Compounds 4b, 4c, and 4d are potent inhibitors of ecto-5'-nucleotidase whereas compound 4a also active but less potent inhibitor. Compound 4b is the most potent inhibitor of phosphoribosyl pyrophosphate (PPRP) synthetase which follows by 4c, 4d and 4a. All of these compounds were more potent inhibitor of PPRP-synthetase than ADP or GDP. Ribavirin imidodiphosphate (4e) was also synthesized and tested for its inhibitory effect on ecto-5'-nucleotidase, PPRP-synthetase as well as IMP dehydrogenase. Compound 4e is the most potent inhibitor of IMP dehyrogenase but was a weak inhibitor of the other two enzymes. compound 4a, 4b, 4c and 4d are weak inhibitors of IMP dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901726      PMCID: PMC338582          DOI: 10.1093/nar/16.17.8645

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  12 in total

Review 1.  ATP analogs.

Authors:  R G Yount
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1975

2.  5'-Nucleotidase from smooth muscle of small intestine and from brain. Inhibition of nucleotides.

Authors:  R M Burger; J M Lowenstein
Journal:  Biochemistry       Date:  1975-06-03       Impact factor: 3.162

3.  Lymphocyte ecto-5'-nucleotidase deficiency in agammaglobulinemia.

Authors:  N L Edwards; D B Magilavy; J T Cassidy; I H Fox
Journal:  Science       Date:  1978-08-18       Impact factor: 47.728

4.  Adenylyl imidodiphosphate, an adenosine triphosphate analog containing a P--N--P linkage.

Authors:  R G Yount; D Babcock; W Ballantyne; D Ojala
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

5.  Nonenzymatic synthesis of oligoadenylates on a polyuridylic acid template.

Authors:  J Sulston; R Lohrmann; L E Orgel; H T Miles
Journal:  Proc Natl Acad Sci U S A       Date:  1968-03       Impact factor: 11.205

6.  Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.

Authors:  M A Becker
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

7.  A phosphorus-magnetic-resonance study of the interaction of Mg2+ with adenyl-5'-yl imidodiphosphate. Binding sites of Mg2+ ion on the phosphate chain.

Authors:  S Tran-Dinh; M Roux
Journal:  Eur J Biochem       Date:  1977-06-01

8.  Alterations of inosinate branchpoint enzymes in cultured human lymphoblasts.

Authors:  H E Gruber; I Jansen; R C Willis; J E Seegmiller
Journal:  Biochim Biophys Acta       Date:  1985-07-30

9.  Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.

Authors:  D G Streeter; J T Witkowski; G P Khare; R W Sidwell; R J Bauer; R K Robins; L N Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

10.  The influence of ribose 5-phosphate availability on purine synthesis of cultured human lymphoblasts and mitogen-stimulated lymphocytes.

Authors:  R B Pilz; R C Willis; G R Boss
Journal:  J Biol Chem       Date:  1984-03-10       Impact factor: 5.157

View more
  1 in total

1.  mRNAs biotinylated within the 5' cap and protected against decapping: new tools to capture RNA-protein complexes.

Authors:  Sylwia Bednarek; Vanesa Madan; Pawel J Sikorski; Ralf Bartenschlager; Joanna Kowalska; Jacek Jemielity
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-11-05       Impact factor: 6.237

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.